Vimarsana
Biggest News Aggregation in the World

Page 7 - River Blindness News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from River Blindness. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In River Blindness Today - Breaking & Trending Today

Experts Decry CDC's Long Pause on Tropical Disease Testing - Vimarsana News

Experts Decry CDC's Long Pause on Tropical Disease Testing

It's been more than 6 months since, for reasons that remain obscure, the CDC discontinued testing for tropical diseases. In a new editorial, several renowned tropical-disease experts demand answers.

Ivermectin Does Not Improve COVID-19 Outcomes - Vimarsana News

Ivermectin Does Not Improve COVID-19 Outcomes

Ivermectin neither reduced hospital admissions for worsening COVID-19 nor shortened the time that infected patients spent in the emergency room, according to data from a large randomized controlled trial.

Study finds ivermectin does not treat COVID-19 - FOX news and MAGA types disagree - Vimarsana News

Study finds ivermectin does not treat COVID-19 - FOX news and MAGA types disagree

On 04/04/2022 at 12:45, DeathLace said: I'm willing to bet there isn't 7 hours of a gap from any president from 1960 onwards, ignoring when they're sleeping. Anyone who thinks otherwise needs to take their horse blinders off... But after watching the Trump Cult eat horse dewormer for the last yea...

Source: neowin.net
Ivermectin Did Not Reduce COVID Hospitalizations, Study Shows - Vimarsana News

Ivermectin Did Not Reduce COVID Hospitalizations, Study Shows

Researchers at McMaster University in Ontario studied around 1,358 COVID patients who were at risk for severe disease because they had diabetes or other conditions.

Lateral flow assays: The possibilities beyond COVID-19 - Vimarsana News

Lateral flow assays: The possibilities beyond COVID-19

In this interview, News-Medical talks to Andre Alfaro from nanoComposix (now a Fortis Life Sciences company) about the possibilities lateral flow assays offer in the post-covid healthscape.